BOLD vs CSX · P/E 0.1, $24.6M cap vs P/E 19, rev $14.09B
Boundless Bio, Inc. Common Stock (BOLD) versus CSX Corporation (CSX) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
CSX Corporation (CSX) is a railroads company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Not investment advice. Open the BOLD and CSX stock pages for the full models.
Not investment advice.